Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
Sarah Mcnamee, Neşe Devenot, Meaghan Buisson
JAMA Psychiatry March 29, 2023 DOI: 10.1001/jamapsychiatry.2023.0099 via OpenAlex
Summary
AI-generated from the abstractSerious adverse events in psychedelic-assisted therapy trials can arise from interactions between therapists and patients. This Viewpoint discusses such events, highlighting the importance of therapeutic relationship dynamics in ensuring participant safety.
Study at a glance
| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Citations | 167 |
| Key finding | Serious adverse events in psychedelic-assisted therapy trials can be linked to therapist-patient interactions. |
Abstract
This Viewpoint discusses serious adverse events linked to interactions between therapists and patients in trials of psychedelic-assisted therapy.